SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArcontech Group Regulatory News (ARC)

Share Price Information for Arcontech Group (ARC)

Share Price is delayed by 15 minutes
Get Live Data
75.50    0.00 (0.00%)
Bid:
73.00
Ask:
78.00
Spread: 5.00 (6.849%)
Market Cap: £10.10m
ARC Live PriceLast checked at - London Stock Exchange

Intraday Arcontech Group Share Chart

Form 8.3 - Arcontech Group PLC

23 Sep 2015 16:37

RNS Number : 0136A
Suresh Chari
23 September 2015
 



FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

Mr Suresh Chari

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Arcontech Limited

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

23 Sep 2015

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

No

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

0.1p Ordinary Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

56500000

3.67

 

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

56500000

3.67

 

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING \THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

None

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

23 Sep 2015

Contact name:

Mr Suresh Chari

Telephone number:

01226 435615

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETPKNDBPBKDOCB
Date   Source Headline
6th Feb 20263:02 pmRNSDirector/PDMR Shareholding
5th Feb 20265:35 pmRNSDirector/PDMR Shareholding
5th Feb 20263:08 pmRNSHolding(s) in Company
5th Feb 20267:00 amRNSInterim Results for the Six Months Ended 31 Dec 25
18th Dec 20251:42 pmRNSGrant of Options
18th Dec 20251:42 pmRNSGrant of Options
23rd Sep 20255:53 pmRNSPosting of Annual Report & Notice of AGM
10th Sep 20257:00 amRNSFinal Results for the year ended 30 June 2025
12th Aug 20257:00 amRNSTrading Update
14th Mar 20257:00 amRNS-RArcontech achieves ISO certifications
5th Mar 20254:26 pmRNSDirector/PDMR Shareholding
3rd Mar 20259:26 amPRNNet Asset Value(s)
26th Feb 20254:44 pmRNSDirector/PDMR Shareholding
26th Feb 20251:03 pmRNSHolding(s) in Company
24th Feb 20257:00 amRNSInterim Results
5th Dec 20245:45 pmRNSGrant of Options
11th Nov 20247:00 amRNSDirector/PDMR Shareholding
9th Oct 20243:53 pmRNSResult of AGM
17th Sep 20244:46 pmRNSPosting of Annual Report & Notice of AGM
2nd Sep 20247:00 amRNSFinal Results
22nd Jul 20247:00 amRNSTrading Update & Notice of Results
21st Feb 20247:00 amRNSInterim Results
27th Oct 20237:00 amRNSNew Client Win
25th Oct 20231:42 pmRNSResult of AGM
3rd Oct 20235:40 pmRNSPosting of Annual Report & Notice of AGM
5th Sep 20237:00 amRNSFinal Results
24th Jul 20237:00 amRNSTrading Update and Notice of Results
10th May 20237:00 amRNSAppointment of consultant in Singapore
6th Apr 202311:45 amRNSDirector/PDMR Shareholding
3rd Apr 20237:00 amRNSDirector Retirement
27th Feb 20237:00 amRNSInterim Results
26th Oct 20223:15 pmRNSBoard Appointment
21st Oct 20227:00 amRNSGrant of Options
17th Oct 20222:41 pmRNSResult of AGM
17th Oct 20222:41 pmRNSResult of AGM
23rd Sep 20224:30 pmRNSPosting of Annual Report & Notice of AGM
12th Sep 20227:00 amRNSFinal Results
30th Aug 20227:00 amRNSNotice of Results
29th Jun 20227:00 amRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSInterim Results
17th Jan 20224:30 pmRNSDirector/PDMR Shareholding
29th Nov 20219:06 amRNSSecond Price Monitoring Extn
29th Nov 20219:00 amRNSPrice Monitoring Extension
29th Nov 20217:00 amRNSTrading Update
15th Oct 20215:32 pmRNSDirector/PDMR Shareholding
12th Oct 20215:00 pmRNSGrant of Options
11th Oct 20217:00 amRNSHolding(s) in Company
1st Oct 20213:30 pmRNSResult of AGM
8th Sep 20217:00 amRNSPosting of Annual Report & Notice of AGM
8th Sep 20217:00 amRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.